(19)
(11) EP 4 823 612 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24904722.6

(22) Date of filing: 10.12.2024
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
C07K 16/18(2006.01)
C07K 16/44(2006.01)
C12N 15/864(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/44; C12N 15/86; C12N 2750/14143; A61K 48/005; A01K 2227/105; A01K 2217/052; A01K 2267/0318; A61P 21/00; A61K 2039/505; C07K 2317/76; C07K 2317/622
(86) International application number:
PCT/US2024/059352
(87) International publication number:
WO 2025/128551 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 11.12.2023 US 202363608667 P
16.02.2024 US 202463554852 P
10.05.2024 US 202463645222 P

(71) Applicants:
  • University of Florida Research Foundation, Incorporated
    Gainesville, FL 32611 (US)
  • The Children's Hospital Of Philadelphia
    Philadelphia, PA 19104 (US)

(72) Inventors:
  • ROMANO, Lisa
    Gainesville, FL 32611 (US)
  • DAVIDSON, Beverly, L.
    Philadelphia, PA 19104 (US)
  • RANUM, Laura
    Gainesville, FL 32611 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) AAV-BASED ANTI-GA THERAPY